Billiontoone (BLLN) Competitors

Billiontoone logo
$97.50 +1.19 (+1.24%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$96.74 -0.76 (-0.78%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BLLN vs. TEM, BTSG, FMS, DVA, and HNGE

Should you buy Billiontoone stock or one of its competitors? Billiontoone's main competitors and comparable companies include Tempus AI (TEM), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), and Hinge Health (HNGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Billiontoone compare to Tempus AI?

Billiontoone (NASDAQ:BLLN) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

24.2% of Tempus AI shares are held by institutional investors. 50.2% of Billiontoone shares are held by company insiders. Comparatively, 24.3% of Tempus AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Billiontoone has a net margin of 10.95% compared to Tempus AI's net margin of -12.54%. Billiontoone's return on equity of 9.16% beat Tempus AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Billiontoone10.95% 9.16% 6.78%
Tempus AI -12.54%-47.00%-9.44%

Billiontoone presently has a consensus target price of $124.38, suggesting a potential upside of 27.56%. Tempus AI has a consensus target price of $79.37, suggesting a potential upside of 25.13%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts plainly believe Billiontoone is more favorable than Tempus AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55
Tempus AI
1 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.45

In the previous week, Tempus AI had 5 more articles in the media than Billiontoone. MarketBeat recorded 11 mentions for Tempus AI and 6 mentions for Billiontoone. Tempus AI's average media sentiment score of 0.77 beat Billiontoone's score of 0.29 indicating that Tempus AI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tempus AI
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Billiontoone has higher earnings, but lower revenue than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M15.27$7.45M$0.92105.98
Tempus AI$1.27B9.10-$245.03M-$1.06N/A

Summary

Billiontoone beats Tempus AI on 10 of the 15 factors compared between the two stocks.

How does Billiontoone compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

BrightSpring Health Services currently has a consensus price target of $77.81, suggesting a potential upside of 11.43%. Billiontoone has a consensus price target of $124.38, suggesting a potential upside of 27.56%. Given Billiontoone's higher probable upside, analysts plainly believe Billiontoone is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
3.11
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

Billiontoone has a net margin of 10.95% compared to BrightSpring Health Services' net margin of 2.69%. BrightSpring Health Services' return on equity of 18.56% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.69% 18.56% 6.03%
Billiontoone 10.95%9.16%6.78%

BrightSpring Health Services has higher revenue and earnings than Billiontoone. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B1.08$190.67M$1.8537.75
Billiontoone$305.11M15.27$7.45M$0.92105.98

In the previous week, Billiontoone had 1 more articles in the media than BrightSpring Health Services. MarketBeat recorded 6 mentions for Billiontoone and 5 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.89 beat Billiontoone's score of 0.29 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

BrightSpring Health Services beats Billiontoone on 8 of the 14 factors compared between the two stocks.

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

In the previous week, Billiontoone had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for Billiontoone and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.38 beat Billiontoone's score of 0.29 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Billiontoone has a net margin of 10.95% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.23%. Billiontoone's return on equity of 9.16% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.23% 9.08% 4.04%
Billiontoone 10.95%9.16%6.78%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Billiontoone. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.52$1.11B$1.7312.55
Billiontoone$305.11M15.27$7.45M$0.92105.98

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $23.43, indicating a potential upside of 7.92%. Billiontoone has a consensus target price of $124.38, indicating a potential upside of 27.56%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts plainly believe Billiontoone is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.58
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Billiontoone beats Fresenius Medical Care AG & Co. KGaA on 10 of the 15 factors compared between the two stocks.

How does Billiontoone compare to DaVita?

Billiontoone (NASDAQ:BLLN) and DaVita (NYSE:DVA) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

Billiontoone presently has a consensus target price of $124.38, indicating a potential upside of 27.56%. DaVita has a consensus target price of $235.86, indicating a potential upside of 36.22%. Given DaVita's stronger consensus rating and higher possible upside, analysts clearly believe DaVita is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55
DaVita
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57

In the previous week, DaVita had 4 more articles in the media than Billiontoone. MarketBeat recorded 10 mentions for DaVita and 6 mentions for Billiontoone. DaVita's average media sentiment score of 0.49 beat Billiontoone's score of 0.29 indicating that DaVita is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
DaVita
2 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

90.1% of DaVita shares are held by institutional investors. 50.2% of Billiontoone shares are held by company insiders. Comparatively, 1.9% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Billiontoone has a net margin of 10.95% compared to DaVita's net margin of 6.49%. Billiontoone's return on equity of 9.16% beat DaVita's return on equity.

Company Net Margins Return on Equity Return on Assets
Billiontoone10.95% 9.16% 6.78%
DaVita 6.49%-225.93%5.42%

DaVita has higher revenue and earnings than Billiontoone. DaVita is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M15.27$7.45M$0.92105.98
DaVita$13.64B0.80$746.80M$13.5812.75

Summary

DaVita beats Billiontoone on 8 of the 15 factors compared between the two stocks.

How does Billiontoone compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

Hinge Health has a net margin of 21.02% compared to Billiontoone's net margin of 10.95%. Hinge Health's return on equity of 66.96% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health21.02% 66.96% 19.70%
Billiontoone 10.95%9.16%6.78%

Billiontoone has lower revenue, but higher earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M15.84-$528.26M$1.9658.45
Billiontoone$305.11M15.27$7.45M$0.92105.98

Hinge Health currently has a consensus target price of $118.93, indicating a potential upside of 3.81%. Billiontoone has a consensus target price of $124.38, indicating a potential upside of 27.56%. Given Billiontoone's higher possible upside, analysts plainly believe Billiontoone is more favorable than Hinge Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.00
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

In the previous week, Hinge Health had 4 more articles in the media than Billiontoone. MarketBeat recorded 10 mentions for Hinge Health and 6 mentions for Billiontoone. Hinge Health's average media sentiment score of 0.55 beat Billiontoone's score of 0.29 indicating that Hinge Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Hinge Health beats Billiontoone on 11 of the 14 factors compared between the two stocks.

Get Billiontoone News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLLN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLLN vs. The Competition

MetricBilliontooneHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$4.60B$10.88B$7.83B$11.74B
Dividend YieldN/A2.54%2.47%4.47%
P/E Ratio105.9836.3134.3428.32
Price / Sales15.272.108.495.70
Price / Cash297.5522.8921.0121.90
Price / Book8.223.574.453.72
Net Income$7.45M$332.46M$3.52B$393.10M
7 Day Performance-11.55%-4.23%-5.93%-5.77%
1 Month Performance-0.63%-1.71%-4.58%-7.14%
1 Year Performance-1.81%19.26%-1.94%-7.46%

Billiontoone Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLLN
Billiontoone
3.4109 of 5 stars
$97.50
+1.2%
$124.38
+27.6%
+4.5%$4.60B$305.11M105.98713
TEM
Tempus AI
3.4736 of 5 stars
$76.05
+8.0%
$79.37
+4.4%
-4.5%$14.16B$1.27BN/A3,800
BTSG
BrightSpring Health Services
3.6792 of 5 stars
$67.15
+2.0%
$77.81
+15.9%
+122.7%$13.18B$12.91B36.3023,500
FMS
Fresenius Medical Care AG & Co. KGaA
3.6608 of 5 stars
$23.39
-1.2%
$23.43
+0.2%
-5.7%$12.03B$22.20B13.521,488
DVA
DaVita
4.4479 of 5 stars
$191.27
-1.8%
$235.86
+23.3%
+47.5%$11.68B$13.64B14.0878,000

Related Companies and Tools


This page (NASDAQ:BLLN) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners